Test bank for Modern Blood Banking and Transfusion Practices 7th Edition by Denise M. Harmening

Test bank for Modern Blood Banking and Transfusion Practices 7th Edition by Denise M. Harmening Table of Contents Chapter 1. Red Blood Cells and Platelet Preservation: Historical Perspectives and Current Trends ............................................. 3 Answer Section .......................................................................................................................................................................... 8 Chapter 2. Basic Genetics ............................................................................................................................................................ 11 Answer Section ........................................................................................................................................................................ 15 Chapter 3. Fundamentals of Immunology.................................................................................................................................... 18 Answer Section ........................................................................................................................................................................ 26 Chapter 4. Concepts in Molecular Biology .................................................................................................................................. 30 Answer Section ........................................................................................................................................................................ 35 Chapter 5. The Antiglobulin Test ................................................................................................................................................ 38 Answer Section ........................................................................................................................................................................ 44 Chapter 6. The ABO Blood Group System ................................................................................................................................. 47 Answer Section ........................................................................................................................................................................ 55 Chapter 7. The Rh Blood Group System ..................................................................................................................................... 59 Answer Section ........................................................................................................................................................................ 64 Chapter 8. Blood Group Terminology and the Other Blood Groups ........................................................................................... 68 Answer Section ........................................................................................................................................................................ 92 Chapter 9. Detection and Identification of Antibodies .............................................................................................................. 102 Answer Section ...................................................................................................................................................................... 112 Chapter 10. Pre-Transfusion Testing ......................................................................................................................................... 116 Answer Section ...................................................................................................................................................................... 124 Chapter 11. Overview of the Routine Blood Bank Laboratory.................................................................................................. 127 Answer Section ...................................................................................................................................................................... 131 Chapter 12. Other Technologies and Automation ..................................................................................................................... 133 Answer Section ...................................................................................................................................................................... 136 Chapter 13. Donor Screening and Component Preparation ....................................................................................................... 138 Answer Section ...................................................................................................................................................................... 142 Chapter 14. Apheresis ................................................................................................................................................................ 144 Answer Section ...................................................................................................................................................................... 150 Chapter 15. Transfusion Therapy .............................................................................................................................................. 156 Answer Section ...................................................................................................................................................................... 169 Chapter 16. Adverse Effects of Blood Transfusion ................................................................................................................... 174 Answer Section ...................................................................................................................................................................... 185 Chapter 17. Cellular Therapy ..................................................................................................................................................... 189 Answer Section ...................................................................................................................................................................... 191 Chapter 18 .................................................................................................................................................................................. 192 Answer Section ...................................................................................................................................................................... 200 Chapter 19. Hemolytic Disease of the Fetus and Newborn ....................................................................................................... 202 Answer Section ...................................................................................................................................................................... 209 Chapter 20. Autoimmune Hemolytic Anemias .......................................................................................................................... 212 1lOMoAR cPSD | Answer Section ...................................................................................................................................................................... 219 Chapter 21. The HLA System .................................................................................................................................................... 223 Answer Section ...................................................................................................................................................................... 228 Chapter 22. Relationship Testing ............................................................................................................................................... 231 Answer Section ...................................................................................................................................................................... 234 Chapter 23. Quality Management .............................................................................................................................................. 236 Answer Section ...................................................................................................................................................................... 239 Chapter 24 .................................................................................................................................................................................. 241 Answer Section ...................................................................................................................................................................... 250 Chapter 25. Transfusion Safety and Federal Regulatory Requirements .................................................................................... 252 Answer Section ...................................................................................................................................................................... 255 Chapter 26. Laboratory Information Systems ............................................................................................................................ 257 Answer Section ...................................................................................................................................................................... 261 Chapter 27. Medicolegal and Ethical Aspects of Providing Blood Collection and Transfusion Services .................................. 263 Answer Section ...................................................................................................................................................................... 267 Chapter 28. Tissue Banking: A New Role for the Transfusion Service ...................................................................................... 269 Answer Section ...................................................................................................................................................................... 271 2lOMoAR cPSD | Chapter 1. Red Blood Cells and Platelet Preservation: Historical Perspectives and Current Trends Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Which metabolic pathway is responsible for generating 90% of the ATP for the RBC? a. Pentose phosphate shunt c. Glycolysis b. Luebering-Rapoport shunt d. Methemoglobin reductase 2. A unit of blood was returned to the blood bank before it was spiked. Apparently the patient’s IV failed. The unit of blood was outside the blood bank for 35 minutes. Which of the statements below is most accurate? a. The unit of blood should be discarded immediately. b. The unit of blood can be returned to inventory. c. The unit of blood must be transfused within 4 hours or be discarded at the end of that time. d. The unit of blood must be transfused with 24 hours. 3. What is the average diameter of a platelet? a. 5 to 10 µm c. 1 to 2 µm b. 2 to 4 µm d. 4 to 6 µm 4. In the normal hemoglobin-oxygen dissociation curve, what percentage of oxygen is released to the tissues when PO2 averages 40 mm Hg? a. 75% c. 100% b. 25% d. 50% 5. What factors are known to influence platelet metabolism and function? a. Storage temperature c. Platelet count b. Initial pH d. All of the above 6. Which of the following red blood cell morphologies may be present on the peripheral blood smear as a result of loss of RBC membrane? a. Spherocytes c. Burr cells b. Target cells d. Schistocytes 7. What does the term autologous transfusion refer to? a. A parent donating blood for his or her child b. An individual donating blood for a friend c. An individual donating blood for a relative d. An individual donating blood for his or her own transfusion 8. What is the primary function of hemoglobin? a. Iron metabolism c. Oxygen transport b. Porphyrin synthesis d. Signal transduction 3lOMoAR cPSD | 9. All of the following areas of red blood cell biology are crucial for normal erythrocyte survival except: a. cellular metabolism. c. site of the ABO antigen attachment. b. RBC membrane. d. hemoglobin structure. 10. What is the correct biochemical composition of the RBC membrane? a. 52% protein, 40% lipid, 8% carbohydrate b. 40% protein, 8% lipid, 52% carbohydrate c. 8% protein, 52% lipid, 40% carbohydrate d. 8% lipid, 40% carbohydrate, 52% protein 11. All of the following biochemical changes are associated with loss of red blood cell viability upon storage except: a. decreased pH. c. increased ATP level. b. loss of red blood cell function. d. decreased glucose consumption. 12. Which red blood cell preservative has a storage time of 35 days? a. ACD c. AS-1 b. CPDA-1 d. CPD 13. The RBC membrane is relatively permeable to all of the following except: a. chloride. c. bicarbonate. b. sodium. d. water. 14. What percentage of platelets is sequestered in the spleen as functional reserve after being released from the bone marrow? a. 30% c. 10% b. 50% d. 25% 15. What is the major biochemical consideration in platelet storage? a. Glucose metabolism c. Production of carbon dioxide b. Oxygen supply d. Regulation of pH 16. What would the hemoglobin-oxygen dissociation curve depict in a patient exhibiting clinical signs of alkalosis? a. Normal c. Shift to the right b. Shift to the left d. None of the above 17. Name the main lipid components of a red blood cell membrane. a. Phospholipid c. Glycolipid b. Sphingomyelin d. Glycophorin A 18. The ABO blood groups were discovered in 1901 by whom? a. Charles Drew c. Loutit and Mollison b. Karl Landsteiner d. Edward Lindeman 4lOMoAR cPSD | 19. A standing order of platelets was shipped to your facility by your supplier. It was inadvertently left in the corner of the department until discovered 36 hours later. What would the appropriate action be for the blood banker? a. If the temperature in the box was 22 +/- 2°C and the platelet swirl seemed OK, it would be OK to accept the unit into inventory. b. The platelets have fallen outside the supplier’s quality assurance. The unit should be discarded because the pH has probably dropped too low and platelet activation has been compromised. c. If the temperature was 1°C to 6°C and the platelet swirl seemed OK, it would be OK to accept the unit into inventory. d. If the platelets appeared OK and passed the platelet swirl test after being placed on the agitator, they could be accepted into the inventory. 20. Which metabolic pathway permits the accumulation of 2,3 diphosphoglycerate (2,3-DPG)? a. Glycolysis c. Pentose phosphate shunt b. Luebering-Rapoport shunt d. Methemoglobin reductase 21. All of the following are consistent with a "shift to the right" of the hemoglobin-oxygen dissociation curve except: a. increased 2,3-DPG. b. 50% O2 saturation to tissues. c. decreased 2,3-DPG. d. decreased hemoglobin affinity for O2. 22. What is the normal platelet count range per cubic millimeter? a. 100 to 350 c. 50,000 to 200,000 b. 150,000 to 350,000 d. 350,000 to 500,000 23. What cryoprotective agent is added to red blood cells upon freezing? a. Dextrose c. Glycerol b. Adsol d. All of the above 24. If platelets are to be stored for 5 days on a rotator, what is the optimal storage temperature? a. 1°C to 6°C c. 35°C to 37°C b. 20°C to 24°C d. 1°C to 10°C 25. What role do platelets play in hemostasis? a. Maintenance of vascular integrity b. Initial arrest of bleeding by platelet plug formation c. Stabilization of the hemostatic plug d. All of the above 26. Which of the following best describes "integral" membrane proteins? a. Reside at the cytoplasmic surface of membrane b. Span the entire membrane surface c. Form the red blood cell cytoskeleton d. None of the above 5lOMoAR cPSD | 27. How is stroma-free hemoglobin solution prepared? a. Outdated red blood cells are concentrated, and stroma is removed. b. Outdated red blood cells are diluted with saline, and stroma is removed. c. Outdated red blood cells are lysed, and stroma is removed. d. None of the above 28. What is the normal life span of an RBC? a. 100 days c. 120 hours b. 120 days d. 2 days 29. Regarding loss of RBC membrane deformability, all of the following are true except: a. increase in ATP level. b. decrease in ATP level. c. increase in calcium level. d. decrease in spectrin phosphorylation level. 30. One of the most important controls of hemoglobin's affinity for oxygen is: a. glucose. c. K+. b. 2,3-diphosphoglycerate (2,3-DPG). d. Ca++. 31. The normal position of the oxygen dissociation curve depends on three ligands normally found within the RBC. Which one of the following is not one of these ligands? a. H+ ions c. 2,3-diphosphoglycerate (2,3-DPG) b. CO2 d. Na+ 32. Which of the following events does not occur while RBCs are stored? a. 2,3-DPG levels increase. b. Potassium levels increase. c. Hgb has a decreased affinity for oxygen carrying capacity. d. 2,3-DPG and potassium levels increase. 33. In order to maintain ATP levels in stored blood, can be added to CPD to extend the shelf-life of stored RBCs from 21 days to 35 days. This new preservative is designated as CPDA- 1. a. mannitol c. adenine and glucose b. adenine saline d. Rejuvenix 34. Which type of blood storage container is no longer available for use in the United States because it may limit the viability of RBCs? a. Glass bottles c. DEHP-free polyolefin containers b. PVC plastic bags with DEHP d. Latex-free plastic containers 35. A rare unit of blood became outdated 48 hours ago but is needed for a patient. Which of the following concepts applies to this situation? 6lOMoAR cPSD | a. The blood could be rejuvenated by adding Rejuvesol, being washed appropriately, and being transfused within 48 hours. b. The blood could be rejuvenated with Rejuvesol, washed, and given immediately to the patient. c. Once a unit is outdated, it is no longer available for use. d. The unit can be rejuvenated immediately, washed, and stored in the appropriate refrigerator until needed later in the week. 36. Hemoglobin-based oxygen carriers have been produced from which of the following sources? a. Bovine c. Recombinant hemoglobin b. Human d. All of the above 37. Which of the following statements about perfluorocarbons (PFCs) is not true? a. PFCs are hydrocarbon structures in which all the hydrogen atoms have been replaced with fluorine. b. PFCs carry oxygen and carbon dioxide by dissolving them. c. PFCs are able to carry oxygen to tissues that are inaccessible, even to RBCs, because of their small size. d. PFCs are currently available for use in the United States and several other countries as a red blood cell substitute. 38. Platelets are anucleated but are composed of organelles. Generally most of these organelles are composed of cytoplastic granules. When stimulated, which one of these granules would be most important in satisfying the metabolic need of the platelet? a. Dense granules c. Lysosomes b. Alpha granules d. Coarse granules 39. Generally, the quality control measurements required by various accreditation organizations for platelet concentrates include: a. platelet concentrate volume and platelet count. b. leukocyte count if claims of leukoreduction are made. c. pH of the unit. d. All of the above 40. Which of the following is not a major factor that influences platelet shape and activation while the platelet is in storage? a. pH c. Agitation b. Volume d. Temperature 41. Proper agitation of platelets while they are being stored is: a. important because when not agitated properly the platelets will stick together and not perform properly when transfused. b. important because the pH of the stored platelets will increase and the platelets will lose functionality. c. important because the pH of the stored platelets will decrease and the platelets will lose functionality. d. not important because it has been deemed unnecessary by the FDA.